This product is intended for research use only and is not suitable for human or veterinary use. The material is tested for solubility in methanol at 50 mg/mL. For use in animal models, various sources note that this compound may be dissolved in DMSO at 25 mg/mL and diluted further with aqueous buffers. Filter sterilization is required.
K2628
Ketotifen fumarate salt
≥99% (TLC), powder, H₁ histamine receptor antagonist
Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
Changer de vue
| À vous/Référence | Disponibilité | Prix |
|---|
A propos de cet article
Formule empirique (notation de Hill) :
C19H19NOS · C4H4O4
Numéro CAS:
Poids moléculaire :
425.50
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
EC Number:
252-100-0
MDL number:
Form:
powder
Le tarif et la disponibilité ne sont pas disponibles actuellement.
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderNom du produit
Ketotifen fumarate salt,
form
powder
Quality Segment
originator
Novartis
SMILES string
OC(=O)\C=C\C(O)=O.CN1CCC(\CC1)=C2/c3ccccc3CC(=O)c4sccc24
InChI
1S/C19H19NOS.C4H4O4/c1-20-9-6-13(7-10-20)18-15-5-3-2-4-14(15)12-17(21)19-16(18)8-11-22-19;5-3(6)1-2-4(7)8/h2-5,8,11H,6-7,9-10,12H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1+
InChI key
YNQQEYBLVYAWNX-WLHGVMLRSA-N
Gene Information
human ... HRH1(3269), PDE7B(27115)
General description
Ketotifen fumarate salt is an antihistamine drug.
Application
Ketotifen fumarate salt has been used: for mast cell product antagonism, as a positive control in β-hexosaminidase release assay, as mast cell stabilizer to treat pregnant dams added to ad libitum drinking water
Biochem/physiol Actions
H1 histamine receptor antagonist.
Ketotifen fumarate plays a key role in preventing histamine release by blocking the histamine H1 receptors. It interferes with the release of histamine, serotonin and other inflammatory mediators from mast cells. It exhibits with anti-allergic activity, anti-inflammatory effects including mast cell stabilization. It has been widely used for ophthalmic allergic conjunctivitis.
Features and Benefits
This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
1 of 1
Cet article | |||
|---|---|---|---|
| description - | description European Pharmacopoeia (EP) Reference Standard | description - | description ≥99% (perchloric acid titration) |
| form powder | form - | form powder | form powder |
| Quality Level 100 | Quality Level - | Quality Level 200 | Quality Level 100 |
| originator Novartis | originator - | originator Sanofi Aventis | originator Bayer |
| Gene Information human ... HRH1(3269), PDE7B(27115) | Gene Information human ... HRH1(3269) | Gene Information human ... HRH1(3269) | Gene Information human ... HRH1(3269) |
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2
Classe de stockage
11 - Combustible Solids
wgk
WGK 3
ppe
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
-
En qué se debe disolver este producto para volverlo una dilución inyectable? Se puede en suero fisiológico?
1 answer-
Helpful?
-